Skip to main content

Currently Skimming:

Appendix B: Workshop Agenda
Pages 125-134

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 125...
... B Workshop Agenda Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws A Workshop March 3–4, 2022 | Virtual Workshop Objectives: A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a 2-day public workshop that brings together experts and key stakeholders to examine the current federal regulatory and legal landscape regarding provision of and access to methadone for the treatment of opioid use disorder. Invited presentations and discussions will be designed to: • Examine current federal regulations governing methadone treat ment services, including the current COVID-19 emergency regula tory relief; • Discuss the impact of these regulations relative to other factors affecting treatment services; • Explore potential options for modifying federal regulations and laws to expand access to quality treatment with methadone; and • Explore state laws that may conflict with federal regulations.
From page 126...
... • What are some of the federal priorities and collaborative efforts aimed at addressing longstanding barriers and improving access to quality treatment? 10:05am Session Overview Helena Hansen, University of California, Los Angeles; Planning Committee Member; Session Moderator 10:10am The Politics of Stigma and Racialization in the Early Years of Methadone Maintenance Regulation Samuel Kelton Roberts, Jr., Columbia University 10:25am Racial Disparities in Access, Initiation, and Retention in Methadone Treatment and Implications for Policy Formulation Magdalena Cerdá, New York University; Planning Committee Member
From page 127...
... Kristi O'Malley, Special Advisor to the Administrator 12:20am Lessons Learned from COVID-19 and Regulatory Change in the Wake of Necessity Noa Krawczyk, New York University
From page 128...
... 1:40pm Session Overview Ken Stoller, Johns Hopkins University; Planning Committee Member; Session Moderator 1:45pm Legal Analysis Bridget Dooling, George Washington University; Planning Committee Member 2:00pm Pharmacy Dispensing as an Extension of OTPs Robert Brooner, Friends Research Institute 2:15pm Mobile Units Valerie Mielke, New Jersey Department of Human Services
From page 129...
... 3:25pm Session Overview Tracie Gardner, Legal Action Center, Planning Committee Member; Session Moderator 3:30pm Crosscutting Regulatory Issues that Impact Corrections Facilities at All Levels and Other Institutions Josiah "Jody" Rich, Brown University; Planning Committee Member 3:45pm Transitional Clinic Networks Emily Wang, Yale School of Medicine
From page 130...
... • Are there available regulatory opportunities not currently understood or leveraged? • What innovations require formal rulemaking or legislative action?
From page 131...
... APPENDIX B 131 9:40am Session Overview Gavin Bart, Hennepin Healthcare; University of Minnesota Medical School; Planning Committee Member; Session Moderator 9:45am Office-Based Methadone Robert Schwartz, Friends Research Institute 10:00am Pharmacy-Based Dispensing Li-Tzy Wu, Duke University School of Medicine 10:15am International Models of Pharmacy-Based Dispensing Janie Sheridan, University of Auckland Suzanne Nielsen, Monash University 10:30am Innovative Models of Initiation under Existing Regulations – Inpatient and Outpatient Settings Alexander Walley, Boston University and Massachusetts Department of Public Health 10:45am Potential New Treatment Modalities/Settings that Could be Opened up with Regulatory Changes Ayana Jordan, New York University Kamilla Venner, University of New Mexico 11:15am BREAK 11:30am Regulatory Opportunities to Remove Current Barriers Corey Davis, The Network for Public Health Law 11:45am Regulatory Incentives to Facilitate Access to Quality Treatment Matthew Lawrence, Emory University School of Law; Planning Committee Member 12:00pm Moderated Discussion with the Speakers and Q&A 12:45pm LUNCH
From page 132...
... 1:30pm Overview Alan Leshner, CEO Emeritus, American Association for the Advancement of Science; Workshop Chair; Session Moderator 1:35pm A Policy Analysis Framework to Support Health Policy Decisions Richard Frank, Harvard Medical School; The Brookings Institution 1:55pm A Cost-Effectiveness Framework to Assess Potential Legal and Regulatory Changes Michael French, University of Miami 2:15pm Moderated Discussion with Speakers and Q&A 2:35pm BREAK 2:50pm Synthesis and Prioritization of Legal and Regulatory Actions Richard Bonnie, University of Virginia, Planning Committee Member
From page 133...
... APPENDIX B 133 3:00pm Panel Discussion on Concrete Actions John Brooklyn, BAART St. Albans and Howard Center Burlington Vermont Chinazo Cunningham, New York State Office of Addiction Services and Supports David Frank, New York University Joy Rucker, Former Executive Director, Texas Harm Reduction Alliance Brendan Saloner, Johns Hopkins University Shelly Weizman, O'Neill Institute for National and Global Health Law, Georgetown Law 3:45pm Audience Q&A 4:25pm Acknowledgments and Concluding Remarks Alan Leshner, CEO Emeritus, American Association for the Advancement of Science; Workshop Chair 4:30pm ADJOURN WORKSHOP


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.